Business & Finance
Grifols closes out 2005 with a 15% increase in sales
Published in Blood Weekly, April 27th, 2006
The increase in demand for Grifols products, principally plasma derivatives such as immunoglobulin intravenous (IgIV) in international markets explains this significant increase in turnover. In 2005, 70% of sales from the group came from international markets and reached EUR 367 million, increasing 22.3% from the previous year. The United States generated EUR 149 million, growing 62.4% compared to 2004. Turnover in Spain was EUR 157 million, 11.3% higher than 2004.
The bioscience division, which includes all products and activities related to plasma for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-04-27)
More Articles from Blood Weekly
- Cardiology
In high-transfusion-risk cardiac surgery, aprotinin and tranexamic acid are similarly effective - Hepatitis C Virus
Hepatitis C virus recurrence and graft fibrosis is treatable following liver transplantation - Tissue Engineering
Cell-cell competition replaces functional organ tissue under nonselective conditions - Tissue Engineering
Neural progenitor and endothelial cells cocultured on hydrogel forms functional vascular networks - Twin-to-Twin Transfusion Syndrome
U.S. FDA approves humanitarian device exemption for treatment of Twin-to-Twin Transfusion syndrome - Arterial Thrombosis
Targeting PAR1-PAR4 may offer opportunity to prevent arterial thrombosis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
